Luyao Ma News Today

SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical Research Institute (Texas Biomed), the University of Alabama at Birmingham (UAB) and Columbia University have developed a promising new human monoclonal antibody that appears a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2.

BorgWarner JV With Shaanxi Fast Group: BorgWarner believes bringing together its cutting-edge technology, customer intimacy, and deep electrification expertise with Shaanxi Fast Auto Drive Group’s commercial vehicle expertise and customer relationships will support the accelerated growth of electrification in the commercial vehicle space.

If self-driving cars can identify objects like other cars or traffic lights, why not use artificial intelligence (AI) to identify harmful bacteria in

A novel type of protein nanoparticle vaccine formulation containing influenza proteins and adjuvant to boost immune responses has provided complete protection against influenza viral challenges, according to a new study published by researchers in the Institute for Biomedical Sciences at Georgia State University.

According to a new study by researchers at Georgia State University Institute of Biomedical Sciences, a new universal flu vaccine has been found to protect ag

Get latest articles and stories on Science at LatestLY. According to a new study by researchers at Georgia State Universitys Institute of Biomedical Sciences, a new universal flu vaccine has been found to protect against influenza B viruses that offer broad defenses against different strains and improve immune protection. Science News | Study Finds Universal Influenza B Vaccine That Induces Broad and Lasting Protection.

According to scientists at Georgia State University’s Institute for Biomedical Sciences, a nanoparticle vaccine that incorporates two proteins that stimulate immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that prompted the disease outbreak, has the chance of growing into broader and safer SARS-CoV-2 vaccines.

A new study has developed an influenza vaccine that is administered through the nose and has been constructed with nanoparticles that increase the immune response and offers stronger protection.

ATLANTA—An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection

An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against